tradingkey.logo

Tandem Diabetes Care Inc

TNDM
View Detailed Chart
21.700USD
-0.800-3.56%
Close 01/09, 16:00ETQuotes delayed by 15 min
1.47BMarket Cap
LossP/E TTM

Tandem Diabetes Care Inc

21.700
-0.800-3.56%
Intraday
1m
30m
1h
D
W
M
D

Today

-3.56%

5 Days

+0.70%

1 Month

+1.17%

6 Months

+34.20%

Year to Date

-1.27%

1 Year

-39.72%

View Detailed Chart

Key Insights

Tandem Diabetes Care Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 80 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 23.09.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Tandem Diabetes Care Inc's Score

Industry at a Glance

Industry Ranking
80 / 208
Overall Ranking
188 / 4562
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Tandem Diabetes Care Inc Highlights

StrengthsRisks
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 17.35% year-on-year.
Fairly Valued
The company’s latest PE is -7.16, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 79.08M shares, decreasing 22.08% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 250.16K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.67.

Analyst Rating

Based on 24 analysts
Buy
Current Rating
23.091
Target Price
-0.26%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Tandem Diabetes Care Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Tandem Diabetes Care Inc Info

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Ticker SymbolTNDM
CompanyTandem Diabetes Care Inc
CEOSheridan (John F)
Websitehttps://www.tandemdiabetes.com/

FAQs

What is the current price of Tandem Diabetes Care Inc (TNDM)?

The current price of Tandem Diabetes Care Inc (TNDM) is 21.700.

What is the symbol of Tandem Diabetes Care Inc?

The ticker symbol of Tandem Diabetes Care Inc is TNDM.

What is the 52-week high of Tandem Diabetes Care Inc?

The 52-week high of Tandem Diabetes Care Inc is 37.930.

What is the 52-week low of Tandem Diabetes Care Inc?

The 52-week low of Tandem Diabetes Care Inc is 9.980.

What is the market capitalization of Tandem Diabetes Care Inc?

The market capitalization of Tandem Diabetes Care Inc is 1.47B.

What is the net income of Tandem Diabetes Care Inc?

The net income of Tandem Diabetes Care Inc is -96.03M.

Is Tandem Diabetes Care Inc (TNDM) currently rated as Buy, Hold, or Sell?

According to analysts, Tandem Diabetes Care Inc (TNDM) has an overall rating of Buy, with a price target of 23.091.

What is the Earnings Per Share (EPS TTM) of Tandem Diabetes Care Inc (TNDM)?

The Earnings Per Share (EPS TTM) of Tandem Diabetes Care Inc (TNDM) is -3.030.
KeyAI